These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17017817)

  • 1. Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics.
    Weissman EM; Zhu CW; Schooler NR; Goetz RR; Essock SM
    J Clin Psychiatry; 2006 Sep; 67(9):1323-6. PubMed ID: 17017817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.
    Hsu C; Ried LD; Bengtson MA; Garman PM; McConkey JR; Rahnavard F
    J Am Pharm Assoc (2003); 2008; 48(3):393-400. PubMed ID: 18595825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration.
    Shi L; Ascher-Svanum H; Chiang YJ; Zhao Y; Fonseca V; Winstead D
    BMC Psychiatry; 2009 Dec; 9():80. PubMed ID: 20021664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.
    Weissman E; Jackson C; Schooler N; Goetz R; Essock S
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):201-7. PubMed ID: 22182457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.
    Garman PM; Ried LD; Bengtson MA; Hsu C; McConkey JR
    J Am Pharm Assoc (2003); 2007; 47(3):373-8. PubMed ID: 17510032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study.
    Saari K; Koponen H; Laitinen J; Jokelainen J; Lauren L; Isohanni M; Lindeman S
    J Clin Psychiatry; 2004 Apr; 65(4):547-50. PubMed ID: 15119919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
    Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
    Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics.
    Vincenzi B; Borba CP; Gray DA; Copeland PM; Wang X; Fan X; Aragam GG; Henderson DC
    Ann Clin Psychiatry; 2013 May; 25(2):141-8. PubMed ID: 23638445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population.
    Perez-Iglesias R; Mata I; Pelayo-Teran JM; Amado JA; Garcia-Unzueta MT; Berja A; Martinez-Garcia O; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2009 Feb; 107(2-3):115-21. PubMed ID: 18993033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan.
    Huang TL; Chen JF
    Schizophr Res; 2005 Dec; 80(1):55-9. PubMed ID: 15964176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
    Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J
    J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychotics.
    O'Donoghue B; Schäfer MR; Becker J; Papageorgiou K; Amminger GP
    Early Interv Psychiatry; 2014 Aug; 8(3):276-80. PubMed ID: 23968390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic.
    Chiliza B; Asmal L; Oosthuizen P; van Niekerk E; Erasmus R; Kidd M; Malhotra A; Emsley R
    Eur Psychiatry; 2015 Feb; 30(2):277-83. PubMed ID: 25577186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemia and atypical antipsychotic drugs.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 18():27-35. PubMed ID: 15600382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?
    Lin EC; Shao WC; Yang HJ; Yen M; Lee SY; Wu PC; Lu RB
    Metab Brain Dis; 2015 Feb; 30(1):107-13. PubMed ID: 25034455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs.
    Paz E; Hermida J; Bouzas L; Brenlla J; Tutor JC
    Clin Biochem; 2008 Aug; 41(12):1002-7. PubMed ID: 18474233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review.
    Spurling RD; Lamberti JS; Olsen D; Tu X; Tang W
    J Clin Psychiatry; 2007 Mar; 68(3):406-9. PubMed ID: 17388710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/Ethnic disparities in monitoring metabolic parameters for patients with schizophrenia receiving antipsychotic medications.
    Phillips KL; Copeland LA; Zeber JE; Stock EM; Tsan JY; MacCarthy AA
    Am J Geriatr Psychiatry; 2015 Jun; 23(6):596-606. PubMed ID: 25154537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics.
    Bruno A; Pandolfo G; Crucitti M; Troili GM; Spina E; Zoccali RA; Muscatello MRA
    Complement Ther Med; 2018 Apr; 37():167-171. PubMed ID: 29609929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of monitoring practices in patients on second generation antipsychotics.
    Nguyen D; Brakoulias V; Boyce P
    Australas Psychiatry; 2009 Aug; 17(4):295-9. PubMed ID: 19585292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.